237 related articles for article (PubMed ID: 9798473)
1. [Management of community-acquired pneumopathies of adults in the city and at the hospital].
Léophonte P
Presse Med; 1998 Sep; 27 Suppl 4():5-7. PubMed ID: 9798473
[No Abstract] [Full Text] [Related]
2. Usefulness of betalactam therapy for community-acquired pneumonia in the era of drug-resistant Streptococcus pneumoniae: a randomized study of amoxicillin-clavulanate and ceftriaxone.
Rosón B; Carratalà J; Tubau F; Dorca J; Liñares J; Pallares R; Manresa F; Gudiol F
Microb Drug Resist; 2001; 7(1):85-96. PubMed ID: 11310807
[TBL] [Abstract][Full Text] [Related]
3. [Management of adult patients with community-acquired pneumonia. Evidence-based guidelines from the Swedish Infectious Diseases Association].
Strålin K; Goscinski G; Hedlund J; Lidman C; Spindler C; Ortqvist A; Holmberg H
Lakartidningen; 2008 Sep 17-23; 105(38):2582-7. PubMed ID: 18846863
[No Abstract] [Full Text] [Related]
4. [Empirical antibacterial therapy of community acquired pneumonia in outpatients].
Yakovlev SV; Suvorova MP
Antibiot Khimioter; 1997; 42(10):23-8. PubMed ID: 9412399
[No Abstract] [Full Text] [Related]
5. [Beta-lactamase producers and other bacteria: which ones to take into consideration and when? The viewpoint of the pneumologist].
Poirier R
Presse Med; 1998 Sep; 27 Suppl 4():14-5. PubMed ID: 9798478
[No Abstract] [Full Text] [Related]
6. Cefuroxime compared to amoxicillin-clavulanic acid in the treatment of community-acquired pneumonia.
Lim TK
Singapore Med J; 1997 Mar; 38(3):139. PubMed ID: 9269388
[No Abstract] [Full Text] [Related]
7. Diagnosis and treatment of community-acquired pneumonia in children.
Korppi M
Acta Paediatr; 2012 Jul; 101(7):702-4. PubMed ID: 22372540
[No Abstract] [Full Text] [Related]
8. A comparison of cefditoren pivoxil and amoxicillin/ clavulanate in the treatment of community-acquired pneumonia: a multicenter, prospective, randomized, investigator-blinded, parallel-group study.
Fogarty CM; Cyganowski M; Palo WA; Hom RC; Craig WA
Clin Ther; 2002 Nov; 24(11):1854-70. PubMed ID: 12501879
[TBL] [Abstract][Full Text] [Related]
9. Impact of antibiotic de-escalation on clinical outcomes in community-acquired pneumococcal pneumonia.
Viasus D; Simonetti AF; Garcia-Vidal C; Niubó J; Dorca J; Carratalà J
J Antimicrob Chemother; 2017 Feb; 72(2):547-553. PubMed ID: 27798219
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of twice-daily pharmacokinetically enhanced amoxicillin/clavulanate (2000/125 mg) in the treatment of adults with community-acquired pneumonia in a country with a high prevalence of penicillin-resistant Streptococcus pneumoniae.
Siquier B; Sánchez-Alvarez J; García-Mendez E; Sabriá M; Santos J; Pallarés R; Twynholm M; Dal-Ré R;
J Antimicrob Chemother; 2006 Mar; 57(3):536-45. PubMed ID: 16446376
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of a new pharmacokinetically enhanced formulation of amoxicillin/clavulanate (2000/125 mg) in adults with community-acquired pneumonia caused by Streptococcus pneumoniae, including penicillin-resistant strains.
File TM; Garau J; Jacobs MR; Wynne B; Twynholm M; Berkowitz E
Int J Antimicrob Agents; 2005 Feb; 25(2):110-9. PubMed ID: 15664480
[TBL] [Abstract][Full Text] [Related]
12. Penicillin and gentamicin therapy vs amoxicillin/clavulanate in severe hypoxemic pneumonia.
Bansal A; Singhi SC; Jayashree M
Indian J Pediatr; 2006 Apr; 73(4):305-9. PubMed ID: 16816491
[TBL] [Abstract][Full Text] [Related]
13. Doxycycline for treatment of community-acquired pneumonia.
Johnson JR
Clin Infect Dis; 2002 Sep; 35(5):632; author reply 632-3. PubMed ID: 12173142
[No Abstract] [Full Text] [Related]
14. Crystalluria.
van Noord C; Wulkan RW; van den Dorpel MA
Neth J Med; 2012 Mar; 70(2):84, 87. PubMed ID: 22418755
[No Abstract] [Full Text] [Related]
15. The efficacy and safety of oral pharmacokinetically enhanced amoxycillin-clavulanate 2000/125 mg, twice daily, versus oral amoxycillin-clavulanate 1000/125 mg, three times daily, for the treatment of bacterial community-acquired pneumonia in adults.
Petitpretz P; Chidiac C; Soriano F; Garau J; Stevenson K; Rouffiac E;
Int J Antimicrob Agents; 2002 Aug; 20(2):119-29. PubMed ID: 12297361
[TBL] [Abstract][Full Text] [Related]
16. [Microbiological diagnosis of community-acquired pneumopathies].
Péan Y
Med Mal Infect; 2011 Jan; 41(1 Suppl 1):H2-4. PubMed ID: 21335251
[No Abstract] [Full Text] [Related]
17. Are third-generation cephalosporins associated with a better prognosis than amoxicillin-clavulanate in patients hospitalized in the medical ward for community-onset pneumonia?
Batard E; Javaudin F; Kervagoret E; Caruana E; Le Bastard Q; Chapelet G; Goffinet N; Montassier E
Clin Microbiol Infect; 2018 Nov; 24(11):1171-1176. PubMed ID: 29964229
[TBL] [Abstract][Full Text] [Related]
18. [Pneumonia--ambulatory management].
Somaini SU; Bonani M; Steurer-Stey C
Praxis (Bern 1994); 2008 Aug; 97(16):871-8; quiz 879-80. PubMed ID: 18777713
[No Abstract] [Full Text] [Related]
19. [Initial empirical antibiotic treatment of community-acquired pneumonia].
Frías J; Gomis M; Prieto J; Mensa J; Bouza E; García-Rodríguez JA; Torres A; Dorca J; Zalacaín R; García de Lomas J
Rev Esp Quimioter; 1998 Sep; 11(3):255-61. PubMed ID: 9795313
[No Abstract] [Full Text] [Related]
20. [Severe acute bronchitis].
Gillissen A
MMW Fortschr Med; 2009 Aug; 151(34-35):49-50. PubMed ID: 19771793
[No Abstract] [Full Text] [Related]
[Next] [New Search]
